Is it time to screen for cardiometabolic factors prior to ART? – Professor Catherine Nelson-Piercy, Guy’s & St Thomas’ Foundation Trust and Imperial College Healthcare NHS Trust, UK
This talk will cover the following:
• The age of women seeking fertility treatment is increasing and the prevalence of obesity and type 2 diabetes is also increasing.
• Cardiac disease is the leading cause of maternal mortality and this is more common in older women and in sub fertile women.
• Some form of cardio metabolic screening is therefore appropriate for women prior to ART.
Professor Catherine Nelson-Piercy is a consultant obstetric physician at Guy’s and St. Thomas’ Hospitals Trust and Queen Charlotte’s and Chelsea Hospital in London. In 2010 she was awarded the title of Professor of Obstetric Medicine at King’s College London. Her undergraduate studies were at King’s College, Cambridge University and St Bartholomew’s Hospital. She trained as a physician and was taught obstetric medicine by Professor Michael de Swiet.
Professor Nelson-Piercy is past President of the International Society of Obstetric Medicine (ISOM). She was founding Co-Editor in Chief of the journal Obstetric Medicine: the medicine of pregnancy.
Professor Nelson-Piercy has been involved in the development of several evidence-based National Guidelines notably for “Contraception in Women with Heart Disease”, BTS / SIGN “Asthma in Pregnancy” and RCOG Green top guidelines on “Reducing the risk of thromboembolism during pregnancy, birth & the puerperium” and ‘Management of nausea vomiting of pregnancy and hyperemesis gravidarum”. She has over 200 publications and has edited five books and written the successful Handbook of Obstetric Medicine, now in its sixth edition. She is also one of the central physician assessors for the UK Confidential maternal deaths enquiry.
The challenge of assessing maternal-child health after IVF – the US experience – Professor Barbara Luke, Michigan State University, USA
This talk aims to:
• Describe the contemporary issues in infertility treatment and their effect on maternal and child health.
• Describe the risk factors associated with pregnancy at older ages and higher plurality, with and without conception by in vitro fertilisation.
• Describe the risks for birth defects and childhood cancer with in vitro fertilisation.
Professor Barbara Luke is Professor of Obstetrics, Gynaecology, and Reproductive Biology at the College of Human Medicine, Michigan State University. She is a reproductive epidemiologist, with degrees from Columbia University in nursing and population studies, New York University in nutrition, and her doctorate from Johns Hopkins in maternal-child health and epidemiology. During her career, her research focus has been women’s health, including national and international collaborative studies on employment during pregnancy, perinatal nutrition, multiple pregnancies, and infertility. Professor Luke created the University Consortium on Multiple Births, researchers from four universities (Johns Hopkins University, Medical University of South Carolina, University of Miami, and University of Michigan) who have collaborated on studies to improve outcomes in multiple pregnancies. She is the recipient of the 2005 Agnes Higgins Award from the March of Dimes for distinguished lifetime achievement in maternal-fetal nutrition. Between 2006-2019, Professor Luke collaborated with the Society for Assisted Reproductive Technology (SART) in a series of National Institute of Health-funded projects to evaluate the health of men, women, and their children after infertility treatment, including linkage of the SART database with State Vital Records, and Birth Defects and Cancer Registries.
Hypertensive disorders in pregnancies conceived using in vitro fertilization – Professor Valerie Baker, Johns Hopkins University School of Medicine, USA